Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers
Marie Tré‐Hardy, Roberto Cupaiolo, Alain Wilmet, Ingrid Beukinga, Laurent Blairon
Topics & Concepts
ImmunogenicityVirologyInterimMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAntibodyInterim analysisImmunologyOutbreakInfectious disease (medical specialty)Clinical trialPolitical scienceInternal medicineLawDiseaseSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyBacillus and Francisella bacterial research